Cargando…
Circulating Tumour Cell Biomarkers in Head and Neck Cancer: Current Progress and Future Prospects
Head and neck cancer (HNC) continues to carry a significant burden of disease both for patients and health services. Facilitating biomarker-led treatment decisions is critical to improve outcomes in this group and deliver therapy tailored to the individual tumour biological profile. One solution to...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6721520/ https://www.ncbi.nlm.nih.gov/pubmed/31387228 http://dx.doi.org/10.3390/cancers11081115 |